Skip to main content


COVID-19 and impact on peer review: As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times.  Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.


Aims and scope

Global Health Research and Policy is an open access, multidisciplinary journal that publishes topic areas and methods addressing global health questions. These include various aspects of health research, such as health equity, health systems and policy, social determinants of health, disease burden, population health and other urgent and neglected global health issues.

Global Health Research and Policy aims to provide a forum for high quality researches on exploring regional and global health improvement and the solution for health equity.

Senior editorial team

Zongfu Mao, Wuhan University, China
Xinguang Chen, University of Florida, USA

Deputy Editor-in-chief
Hao Li, Wuhan University, China

Managing Editor
Don Eliseo Lucero-Prisno III, Wuhan University, China

Editorial Director
Hao Li, Wuhan University, China

Information for authors

The publication costs for Global Health Research and Policy are covered by the Global Health Institute of Wuhan University, so authors do not need to pay an article-processing charge for each article accepted for publication.

New Content ItemCall for papers

We invite you to submit an article to the topic: The Governance of New Coronavirus Pandemic: Bridging Research and Policy, to share with the public the latest knowledge on the disease. The editorial office is dedicated to process the submissions with high priority.

The APCs will be covered by Global Health Institute of Wuhan University, no charge to authors.

In December 2019, the first patient infected with coronavirus(2019-nCoV, or COVID-19, or SARS-COV-2)was identified in Wuhan, China.   The outbreak developed from a localized epidemic to a Public Health Emergency of International Concern (PHEIC) as declared by the World Health Organization and has generated an extensive impact on the world. It is a typical emerging infectious disease that has been found to have a long incubation period and which can be transmitted via droplets, or person-to-person contact, etc. To generate policy recommendations and provide input for different countries to put in place a comprehensive governance framework on the outbreak so as to undertake effective measures, the Global Health Research and Policy (GHRP), through a thematic series, publishes recent progress and findings about the epidemic with the following themes:

  1. Relevant estimation and evaluation models, such as outbreak simulations, disease burden, socioeconomic burden, etc. 
  2. Governance system research, such as multilateral collaboration mechanisms among public and private players.
  3. Health system strengthening, such as the development of an emergency response system, financing, assistance, etc.
  4. Surveillance, public reporting and formulation of relevant laws and regulations 
  5. Comparative study between COVID-19 and SARS, Ebola, MERS, etc. focusing on the prevention and control so as to generate governance policy recommendations
  6. Relevant guidelines at the hospital, community and individual levels
  7. Comprehensive summary of each country’s actions and experience in response to the COVID-19 outbreak and their implications to other countries
  8. Understanding of the impact of the outbreak in China, the globe, and other countries
  9. Other relevant clinical and laboratory research which can generate policy implications

For more information, please refer to the submission guidelines

View articles in this thematic series.

Latest Collections

The Governance of New Coronavirus Pandemic: Bridging Research and Policy
Guest edited by Prof. Hao Li, Prof. Xinguang Chen, Prof. Don Eliseo Lucero-Prisno III, Prof. Abu S. Abdullah

China-UK Joint Contribution to Global Health: Selected GHSP Findings and Policy Implications

Guest edited by Dr. Hao Li, Ms Xiaohua Wang, Dr. Charlotte Laurence and Prof. Tongwu Xu

Universal Health Coverage

Guest Edited by Dr. Beibei Yuan, Dr. Lanting Lu and Dr. Don Eliseo Lucero-Prisno III


Annual Journal Metrics

  • Speed
    49 days to first decision for reviewed manuscripts only
    26 days to first decision for all manuscripts
    112 days from submission to acceptance
    23 days from acceptance to publication

    284 Altmetric mentions